Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
VANCOUVER, Dec. 5, 2019 /CNW/ - Pivot Pharmaceuticals Inc. today announced its corporate name change to BetterLife Pharma Inc. The Company will change its ticker symbol to BETR. taking effect...
Health Canada licensing documentation in preparation; production to start in next 90 days VANCOUVER, Nov. 25, 2019 /CNW/ - Pivot Pharmaceuticals Inc. ("Pivot") (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT)...
VANCOUVER, Oct. 8, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) has entered into a contract manufacturing and supply agreement with F&B Cosmetics to manufacture...
VANCOUVER, Sept. 19, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT /OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company"), is responding to the Stockwatch Article dated September 18, 2019...
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com VANCOUVER, Sept. 11, 2019...
VANCOUVER, Sept. 5, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) is pleased to announce that it has entered into a binding letter of intent to acquire 51% of...
Dr. Wolfgang Renz, Chief Medical Officer, takes on additional responsibilities as Regional Manager Europe VANCOUVER, Aug. 19, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA:...
VANCOUVER, July 9, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") announces that it has hired Mr. Russell Starr as its President. Mr. Starr...
VANCOUVER, June 24, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") announces that it has appointed Mr. Chris Lucky as its Chief Operating...
VANCOUVER, May 31, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") announces that it has closed the final tranche of its oversubscribed...
VANCOUVER, May 21, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has placed an initial production order for...
Use of Proceeds Includes Repayment of Outstanding $2.75M Convertible Debentures VANCOUVER, May 15, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the...
VANCOUVER, May 2, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") announces that it filed a protective lawsuit on April 23, 2019 in the Supreme Court of...
VANCOUVER, April 25, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce that it has retained the law firm, Harris Bricken LLP, to...
Joe Mimran to Join Advisory Committee; Krisztian Toth Appointed to Board of Directors VANCOUVER, April 9, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or...
VANCOUVER, April 8, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has closed a non-brokered Private...
VANCOUVER, April 3, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent, dated...
VANCOUVER, April 1, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce that it has signed an agreement with Shopify Inc. ("Shopify"), ...
Hemp-derived CBD Capsules, Tablets, Topical Creams and Roll-on Gels to Enter US Market VANCOUVER, March 28, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the...
Appoints MNP LLP As Auditor VANCOUVER, March 7, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has closed a...
Formulated Using Pivot's Thrudermic™ Transdermal Nanotechnology VANCOUVER, Feb. 15, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is...
Patented Topical Gels, Creams and Beverages to be Manufactured for California Market VANCOUVER, Jan. 28, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the ...
Strategic Partnership Includes Distribution and Product Development Agreements VANCOUVER, Dec. 20, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the...
New Entity to Commercialize Cannabis-Infused Beverages VANCOUVER, Dec. 18, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to...
Allows Pivot to Start Production of CBD and THC Ingestibles and Edibles COSTA MESA, CA, Nov. 28, 2018 /CNW/ - Pivot Naturals LLC, a wholly owned subsidiary of Pivot Pharmaceuticals Inc. (CSE: PVOT /...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.